Table 2.
Predictors of Weight Change Adjusted for Follow-up Time in Adults with Type 1 Diabetes
| Weight change | ||
|---|---|---|
| β (SE) | p-value | |
| Age (years) | −0.19 (0.15) | 0.21 |
| Diabetes duration (years) | −0.12 (0.15) | 0.43 |
| HbA1c (%) | 0.35 (0.15) | 0.03 |
| Insulin dose (U/kg/dy) | 0.10 (0.16) | 0.54 |
| Insulin injections/day* | −0.02 (0.15) | 0.88 |
| Physical activity (kcal/week)* | 0.15 (0.16) | 0.35 |
| Sex (female) | −0.16 (0.30) | 0.58 |
| Coronary artery disease | −0.21 (0.58) | 0.72 |
| Overt nephropathy | −0.78 (0.35) | 0.03 |
| Proliferative Retinopathy | 0.10 (0.33) | 0.76 |
| Symptomatic autonomic neuropathy | −1.41 (0.61) | 0.02 |
| Distal symmetrical polyneuropathy | −0.55 (0.34) | 0.11 |
| Lower extremity arterial disease | −0.53 (0.55) | 0.34 |
| Intensive insulin therapy: | ||
| Incident during follow-up vs Never | 0.77 (0.37) | 0.04 |
| Family history of T2D | 0.39 (0.43) | 0.36 |
| Annual Household Income <$20,000 | 0.34 (0.34) | 0.31 |
| Some college | 0.006 (0.33) | 0.98 |
| Current smoker | 0.08 (0.36) | 0.83 |
| Alcohol consumption: 3+gl/wk | −0.36 (0.36) | 0.31 |
Weight change was represented as the residuals of baseline BMI regressed on BMI at last follow-up. BMI units=kg/m2
*
Natural-logarithmically transformed before analysis.